Cohu, Inc. balance sheet COHU

As of Sep 26, 2026, Cohu, Inc. had total assets of $1.3 billion. Total assets were up 27.1% from a year earlier. Stockholders' equity was $791.0 million. It held $507.9 million in cash and investments against $335.9 million of total debt, net cash of $172.1 million. The current ratio, current assets divided by current liabilities, was 5.16.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Line
Q3 FY2026
Sep 26, 2026
Q2 FY2026
Jun 27, 2026
Q1 FY2026
Mar 28, 2026
Q4 FY2025
Dec 27, 2025
Q3 FY2025
Sep 27, 2025
Q2 FY2025
Jun 28, 2025
Q1 FY2025
Mar 29, 2025
Q4 FY2024
Dec 28, 2024
Assets
Cash
272
+81.6%
220
+33.6%
211
+38.9%
227
+10.0%
150
-20.8%
164
-19.0%
152
-20.5%
206
-15.9%
Short-term investments
236
+388.8%
279
+519.4%
278
+467.6%
257
+361.4%
48
-39.7%
45
-24.2%
49
-39.0%
56
-38.2%
Cash and investments
508
+156.3%
498
+137.9%
489
+143.4%
484
+84.7%
198
-26.4%
209
-20.2%
201
-26.0%
262
-21.9%
Inventory
149
+11.0%
140
+1.8%
131
-6.1%
129
-9.1%
134
-6.9%
138
-5.6%
139
-8.1%
142
-8.9%
Total current assets
836
+62.9%
789
+60.6%
754
+57.5%
750
+40.4%
514
-5.3%
491
-10.1%
479
-16.4%
534
-16.4%
Property and equipment, net
75
-2.3%
75
-2.1%
77
+0.9%
77
+2.9%
77
+0.6%
77
+2.9%
76
-0.5%
75
+8.3%
Goodwill
279
-1.3%
279
-1.3%
280
+2.8%
283
+20.6%
282
+16.2%
283
+19.0%
273
+14.4%
235
-2.9%
Total assets
1,298
+27.1%
1,258
+24.6%
1,235
+26.6%
1,243
+24.4%
1,021
-1.1%
1,010
-2.8%
976
-9.2%
999
-13.1%
Liabilities and equity
Accounts payable
77
+49.2%
62
+52.5%
49
+58.9%
41
+33.2%
51
+119.0%
41
+88.5%
31
+1.8%
31
-9.1%
Total current liabilities
162
+38.8%
137
+36.6%
117
+27.5%
109
+28.0%
117
+37.6%
101
+28.0%
92
+1.0%
85
-17.6%
Stockholders' equity
791
-4.8%
775
-6.7%
769
-7.1%
786
-8.3%
831
-6.0%
831
-7.3%
828
-9.6%
857
-9.8%
Debt
Debt due within a year
17
+53.8%
11
+0.9%
11
+3.6%
20
+1047.8%
11
+320.5%
11
+365.9%
11
+280.1%
2
-73.4%
Long-term debt
285
+4044.9%
285
+3830.1%
285
+3937.2%
285
+3941.8%
7
-13.1%
7
-4.5%
7
-12.0%
7
-79.4%
Lease liabilities
34
-5.8%
35
-4.8%
34
+142.2%
35
+47.4%
36
+46.4%
37
+51.6%
14
-44.6%
24
+90696.2%
Total debt
336
+525.0%
331
+501.1%
330
+938.9%
340
+948.8%
54
+53.3%
55
+61.0%
32
-12.2%
32
-20.8%
Net cash
172
+19.1%
167
+8.2%
159
-6.2%
144
-37.3%
144
-38.3%
154
-32.4%
169
-28.1%
230
-22.1%
Ratios
Current ratio
5.16x
5.74x
6.43x
6.88x
4.39x
4.88x
5.20x
6.27x
Debt to equity
0.42x
0.43x
0.43x
0.43x
0.06x
0.07x
0.04x
0.04x
Debt to EBITDA
11.95x
37.16x
—
—
—
—
—
—
Return on equity
-2.86%
-5.01%
-7.22%
-9.46%
-8.80%
-10.49%
-10.39%
-8.15%
Return on assets
-1.74%
-3.08%
-4.50%
-5.98%
-7.16%
-8.62%
-8.81%
-6.99%
Book value per share
15.71
15.39
15.33
15.75
16.71
16.70
16.69
17.28
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Instruments For Meas & Testing of Electricity & Elec Signals (SIC 3825)
Listed as
COHU (Nasdaq)
Fiscal year ends
December 26
Incorporated in
DE
Headquarters
Poway, CA
SEC filer status
Large accelerated filer
SEC CIK
21535

Other Instruments For Meas & Testing of Electricity & Elec Signals companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.